Table 1.
Clinical features of Hashimoto's thyroiditis (HT) patients and healthy controls included in the study
| HT patients | Healthy controls | Range | P | |
|---|---|---|---|---|
| Number | 27 | 20 | ||
| Sex | Female | Female | ||
| Age (years) | 49·96 ± 10·94 | 45·85 ± 10·14 | n.s. | |
| BMI (kg/m2) | 22·94 ± 2·81 | 23·67 ± 3·17 | n.s. | |
| FT3 (pmol/l) | 4·33 ± 0·94 | 4·72 ± 0·80 | 3·10–6·80 | n.s. |
| FT4 (pmol/l) | 16·37 ± 2·60 | 15·79 ± 2·25 | 12·00–22·00 | n.s. |
| Tg antibodies (IU/ml) | 272·1 ± 182·4 | 7·1 ± 2·1 | <30 | <0·001 |
| TPO antibodies (IU/ml) | 364·2 ± 275·8 | 15·7 ± 5·3 | <10 | <0·001 |
Data correspond to the arithmetic mean ± standard deviation, BMI: body mass index; n.s.: not significant; Tg: thyroglobulin; TPO: thyroperoxidase.